CYSLTR1 and asthma: A large nationwide retrospective cohort study using the Taiwan National Health Insurance Research Database investigated the effect of CysLTR antagonists (LTRAs), including montelukast and zafirlukast, in reducing cancer incidence in asthma patients [105].